News

Luminoah closes $6M Series A round

Charlottesville medical device company Luminoah Inc. has closed a $6 million Series A round it says it will use to complete the development of its mobile feeding tube device that collects data.

The round was led by Charlottesville’s Fry’s Path Capital and included participation from Arlington’s Sands Capital, Charlottesville’s CAV Angels, Virginia Beach’s 757 Angels and Richmond’s Virginia Venture Partners — the equity investment arm of the Virginia Innovation Partnership Corp.

Luminoah, which took top honors at the Light House Labs’ Demo Day competition last month, says its device lets patients to keep a more mobile lifestyle while on a feeding tube. Its data-tracking features also allow remote patient monitoring.

CEO Neal Piper started the company after his young son was diagnosed with cancer and required a constraining feeding tube.

“It’s just a no-brainer to let a kid be active while you pump nutrition into their stomach,” Piper told Richmond Inno last month.

Piper said the goal is to apply for Food and Drug Administration approval in 2024. Luminoah wants to go after the pediatric home health care market initially, but also seeks to move into senior and rehabilitation markets. The company says the enteral feeding technology market is worth about $12 billion and that half-a-million children could benefit from its product.

Learn more here.

Recent News

01/21/2025

MicroAire Completes Acquisition of NEOSYAD

MicroAire Surgical Instruments, the global leader in power-assisted liposuction, is pleased to announce the acquisition of NEOSYAD, an innovative medical device company that developed a breakthrough technology for adipose tissue engineering. This strategic move reinforces MicroAire’s commitment to advancing medical innovation and strengthening its leadership in the adipose tissue market. NEOSYAD recently received EU MDR

01/17/2025

ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer

ATCC, the world’s premier biological materials management and standards organization, today announced the appointment of Ruth Cheng, PhD, as president and chief executive officer. Dr. Cheng, who has been with ATCC for five years and most recently served as senior vice president and general manager, Research and Industrial Solutions, succeeds Raymond H. Cypess, DVM, PhD, who

01/15/2025

Alliance for Building Better Medicine Partners Secure $3.94 Million Federal Grant to Strengthen Richmond-Petersburg Region’s Pharma and Biotech Workforce and Talent System

Under the leadership of Alliance-member organization J. Sargeant Reynolds Community College (Reynolds), the Alliance for Building Better Medicine has secured a landmark $3.94 million federal grant through the U.S. Economic Development Administration’s (EDA) Good Jobs Challenge Award. The funding will support the Richmond-Petersburg Advanced Pharmaceutical Manufacturing (APM) Workforce Initiative. This transformative project, led by Reynolds